Sign In

Login

Password

Forgot Password ? Sign Up

Arylcyclohexylamine (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Arylcyclohexylamine" in French language version.

refsWebsite
Global rank French rank
18nih.gov
4th place
12th place
18doi.org
2nd place
3rd place
15wikipedia.org
low place
low place
1wiley.com
222nd place
129th place

doi.org

dx.doi.org

  • H. Morris et J. Wallach, « From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs », Drug Testing and Analysis, vol. 6, nos 7-8,‎ , p. 614–32 (PMID 24678061, DOI 10.1002/dta.1620, lire en ligne)
  • A. Ahmadi et A. Mahmoudi, « Synthesis and biological properties of 2-hydroxy-1-(1-phenyltetralyl)piperidine and some of its intermediates as derivatives of phencyclidine », Arzneimittel-Forschung, vol. 55, no 9,‎ , p. 528–532 (PMID 16229117, DOI 10.1055/s-0031-1296900) modifier
  • A. Ahmadi, M. Khalili, R. Hajikhani et M. Naserbakht, « New morpholine analogues of phencyclidine: Chemical synthesis and pain perception in rats », Pharmacology Biochemistry and Behavior, vol. 98, no 2,‎ , p. 227–233 (PMID 21215770, DOI 10.1016/j.pbb.2010.12.019) modifier
  • I. Chaudieu, Vignon, Chicheportiche, Kamenka, Trouiller et Chicheportiche, « Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs », Pharmacology, Biochemistry, and Behavior, vol. 32, no 3,‎ , p. 699–705 (PMID 2544905, DOI 10.1016/0091-3057(89)90020-8) modifier
  • X. S. He, L. P. Raymon, M. V. Mattson, M. E. Eldefrawi et B. R. De Costa, « Synthesis and biological evaluation of 1-1-(2-benzobthienyl)cyclohexylpiperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites », Journal of Medical Chemistry, vol. 36, no 9,‎ , p. 1188–1193 (PMID 8098066, DOI 10.1021/jm00061a009) modifier
  • P. Seeman, F. Ko et T. Tallerico, « Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics », Molecular Psychiatry, vol. 10, no 9,‎ , p. 877–883 (PMID 15852061, DOI 10.1038/sj.mp.4001682) modifier
  • (en) D. Lednicer et P. F. Vonvoigtlander, « 4-(p-Bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol, an extremely potent representative of a new analgesic series », Journal of Medicinal Chemistry, vol. 22, no 10,‎ , p. 1157–1158 (PMID 513062, DOI 10.1021/jm00196a001) modifier
  • T. Maurice, T. P. Su, D. W. Parish, T. Nabeshima et A. Privat, « PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice », Pharmacology, Biochemistry, and Behavior, vol. 49, no 4,‎ , p. 859–869 (PMID 7886099, DOI 10.1016/0091-3057(94)90235-6) modifier
  • DOI 10.1021/jm00167a027
  • C. Sauer, F. Peters, R. Staack, G. Fritschi et H. Maurer, « Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry », Journal of Chromatography A, vol. 1186, nos 1–2,‎ , p. 380–390 (PMID 18035363, DOI 10.1016/j.chroma.2007.11.002) modifier
  • C. Sauer, F. Peters, A. Schwaninger, M. Meyer et H. Maurer, « Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine », Biochemical pharmacology, vol. 77, no 3,‎ , p. 444–450 (PMID 19022226, DOI 10.1016/j.bcp.2008.10.024) modifier
  • M. A. Iorio, L. Tomassini, M. V. Mattson, C. George et A. E. Jacobson, « Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine », Journal of Medicinal Chemistry, vol. 34, no 8,‎ , p. 2615–2623 (PMID 1875352, DOI 10.1021/jm00112a041) modifier
  • A. Ahmadi et A. Mahmoudi, « Synthesis with improved yield and study on the analgesic effect of 2-methoxyphencyclidine », Arzneimittel-Forschung, vol. 56, no 5,‎ , p. 346–350 (PMID 16821645, DOI 10.1055/s-0031-1296732) modifier
  • DOI 10.1016/S0022-1139(01)00565-6
  • J. Wallach, G. D. Paoli, A. Adejare et S. D. Brandt, « Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues », Drug Testing and Analysis, vol. 6, nos 7–8,‎ , p. 633–50 (PMID 23554350, DOI 10.1002/dta.1468) modifier
  • Ahmadi A, Khalili M, Hajikhani R, Naserbakht M, « New morpholine analogues of phencyclidine: chemical synthesis and pain perception in rats », Pharmacology, Biochemistry, and Behavior, vol. 98, no 2,‎ , p. 227–33 (PMID 21215770, DOI 10.1016/j.pbb.2010.12.019)
  • Ahmadi A, Khalili M, Hajikhani R, Naserbakht M, « Synthesis and determination of acute and chronic pain activities of 1-[1-(4-methylphenyl) (cyclohexyl)] morpholine as a new phencyclidine derivative in rats », Arzneimittel-Forschung, vol. 61, no 2,‎ , p. 92–7 (PMID 21428243, DOI 10.1055/s-0031-1296173)
  • J. Vignon, V. Pinet, C. Cerruti, J. M. Kamenka et R. Chicheportiche, « 3HN-1-(2-benzo(b)thiophenyl)cyclohexylpiperidine (3HBTCP): A new phencyclidine analog selective for the dopamine uptake complex », European Journal of Pharmacology, vol. 148, no 3,‎ , p. 427–436 (PMID 3384005, DOI 10.1016/0014-2999(88)90122-7) modifier

nih.gov

ncbi.nlm.nih.gov

  • H. Morris et J. Wallach, « From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs », Drug Testing and Analysis, vol. 6, nos 7-8,‎ , p. 614–32 (PMID 24678061, DOI 10.1002/dta.1620, lire en ligne)
  • A. Ahmadi et A. Mahmoudi, « Synthesis and biological properties of 2-hydroxy-1-(1-phenyltetralyl)piperidine and some of its intermediates as derivatives of phencyclidine », Arzneimittel-Forschung, vol. 55, no 9,‎ , p. 528–532 (PMID 16229117, DOI 10.1055/s-0031-1296900) modifier
  • A. Ahmadi, M. Khalili, R. Hajikhani et M. Naserbakht, « New morpholine analogues of phencyclidine: Chemical synthesis and pain perception in rats », Pharmacology Biochemistry and Behavior, vol. 98, no 2,‎ , p. 227–233 (PMID 21215770, DOI 10.1016/j.pbb.2010.12.019) modifier
  • I. Chaudieu, Vignon, Chicheportiche, Kamenka, Trouiller et Chicheportiche, « Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs », Pharmacology, Biochemistry, and Behavior, vol. 32, no 3,‎ , p. 699–705 (PMID 2544905, DOI 10.1016/0091-3057(89)90020-8) modifier
  • Y. Itzhak et Simon, « A novel phencyclidine analog interacts selectively with mu opioid receptors », The Journal of Pharmacology and Experimental Therapeutics, vol. 230, no 2,‎ , p. 383–386 (PMID 6086884) modifier
  • X. S. He, L. P. Raymon, M. V. Mattson, M. E. Eldefrawi et B. R. De Costa, « Synthesis and biological evaluation of 1-1-(2-benzobthienyl)cyclohexylpiperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites », Journal of Medical Chemistry, vol. 36, no 9,‎ , p. 1188–1193 (PMID 8098066, DOI 10.1021/jm00061a009) modifier
  • V. A. Eterović, R. Lu, A. E. Eakin, A. D. Rodríguez et P. A. Ferchmin, « Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ », Cellular and molecular neurobiology, vol. 19, no 6,‎ , p. 745–757 (PMID 10456235) modifier
  • P. Seeman, F. Ko et T. Tallerico, « Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics », Molecular Psychiatry, vol. 10, no 9,‎ , p. 877–883 (PMID 15852061, DOI 10.1038/sj.mp.4001682) modifier
  • (en) D. Lednicer et P. F. Vonvoigtlander, « 4-(p-Bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol, an extremely potent representative of a new analgesic series », Journal of Medicinal Chemistry, vol. 22, no 10,‎ , p. 1157–1158 (PMID 513062, DOI 10.1021/jm00196a001) modifier
  • T. Maurice, T. P. Su, D. W. Parish, T. Nabeshima et A. Privat, « PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice », Pharmacology, Biochemistry, and Behavior, vol. 49, no 4,‎ , p. 859–869 (PMID 7886099, DOI 10.1016/0091-3057(94)90235-6) modifier
  • C. Sauer, F. Peters, R. Staack, G. Fritschi et H. Maurer, « Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry », Journal of Chromatography A, vol. 1186, nos 1–2,‎ , p. 380–390 (PMID 18035363, DOI 10.1016/j.chroma.2007.11.002) modifier
  • C. Sauer, F. Peters, A. Schwaninger, M. Meyer et H. Maurer, « Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine », Biochemical pharmacology, vol. 77, no 3,‎ , p. 444–450 (PMID 19022226, DOI 10.1016/j.bcp.2008.10.024) modifier
  • M. A. Iorio, L. Tomassini, M. V. Mattson, C. George et A. E. Jacobson, « Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine », Journal of Medicinal Chemistry, vol. 34, no 8,‎ , p. 2615–2623 (PMID 1875352, DOI 10.1021/jm00112a041) modifier
  • A. Ahmadi et A. Mahmoudi, « Synthesis with improved yield and study on the analgesic effect of 2-methoxyphencyclidine », Arzneimittel-Forschung, vol. 56, no 5,‎ , p. 346–350 (PMID 16821645, DOI 10.1055/s-0031-1296732) modifier
  • J. Wallach, G. D. Paoli, A. Adejare et S. D. Brandt, « Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues », Drug Testing and Analysis, vol. 6, nos 7–8,‎ , p. 633–50 (PMID 23554350, DOI 10.1002/dta.1468) modifier
  • Ahmadi A, Khalili M, Hajikhani R, Naserbakht M, « New morpholine analogues of phencyclidine: chemical synthesis and pain perception in rats », Pharmacology, Biochemistry, and Behavior, vol. 98, no 2,‎ , p. 227–33 (PMID 21215770, DOI 10.1016/j.pbb.2010.12.019)
  • Ahmadi A, Khalili M, Hajikhani R, Naserbakht M, « Synthesis and determination of acute and chronic pain activities of 1-[1-(4-methylphenyl) (cyclohexyl)] morpholine as a new phencyclidine derivative in rats », Arzneimittel-Forschung, vol. 61, no 2,‎ , p. 92–7 (PMID 21428243, DOI 10.1055/s-0031-1296173)
  • J. Vignon, V. Pinet, C. Cerruti, J. M. Kamenka et R. Chicheportiche, « 3HN-1-(2-benzo(b)thiophenyl)cyclohexylpiperidine (3HBTCP): A new phencyclidine analog selective for the dopamine uptake complex », European Journal of Pharmacology, vol. 148, no 3,‎ , p. 427–436 (PMID 3384005, DOI 10.1016/0014-2999(88)90122-7) modifier

wikipedia.org

fr.wikipedia.org

  • A. Ahmadi et A. Mahmoudi, « Synthesis and biological properties of 2-hydroxy-1-(1-phenyltetralyl)piperidine and some of its intermediates as derivatives of phencyclidine », Arzneimittel-Forschung, vol. 55, no 9,‎ , p. 528–532 (PMID 16229117, DOI 10.1055/s-0031-1296900) modifier
  • A. Ahmadi, M. Khalili, R. Hajikhani et M. Naserbakht, « New morpholine analogues of phencyclidine: Chemical synthesis and pain perception in rats », Pharmacology Biochemistry and Behavior, vol. 98, no 2,‎ , p. 227–233 (PMID 21215770, DOI 10.1016/j.pbb.2010.12.019) modifier
  • I. Chaudieu, Vignon, Chicheportiche, Kamenka, Trouiller et Chicheportiche, « Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs », Pharmacology, Biochemistry, and Behavior, vol. 32, no 3,‎ , p. 699–705 (PMID 2544905, DOI 10.1016/0091-3057(89)90020-8) modifier
  • Y. Itzhak et Simon, « A novel phencyclidine analog interacts selectively with mu opioid receptors », The Journal of Pharmacology and Experimental Therapeutics, vol. 230, no 2,‎ , p. 383–386 (PMID 6086884) modifier
  • X. S. He, L. P. Raymon, M. V. Mattson, M. E. Eldefrawi et B. R. De Costa, « Synthesis and biological evaluation of 1-1-(2-benzobthienyl)cyclohexylpiperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites », Journal of Medical Chemistry, vol. 36, no 9,‎ , p. 1188–1193 (PMID 8098066, DOI 10.1021/jm00061a009) modifier
  • V. A. Eterović, R. Lu, A. E. Eakin, A. D. Rodríguez et P. A. Ferchmin, « Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ », Cellular and molecular neurobiology, vol. 19, no 6,‎ , p. 745–757 (PMID 10456235) modifier
  • P. Seeman, F. Ko et T. Tallerico, « Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics », Molecular Psychiatry, vol. 10, no 9,‎ , p. 877–883 (PMID 15852061, DOI 10.1038/sj.mp.4001682) modifier
  • (en) D. Lednicer et P. F. Vonvoigtlander, « 4-(p-Bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol, an extremely potent representative of a new analgesic series », Journal of Medicinal Chemistry, vol. 22, no 10,‎ , p. 1157–1158 (PMID 513062, DOI 10.1021/jm00196a001) modifier
  • T. Maurice, T. P. Su, D. W. Parish, T. Nabeshima et A. Privat, « PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice », Pharmacology, Biochemistry, and Behavior, vol. 49, no 4,‎ , p. 859–869 (PMID 7886099, DOI 10.1016/0091-3057(94)90235-6) modifier
  • C. Sauer, F. Peters, R. Staack, G. Fritschi et H. Maurer, « Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry », Journal of Chromatography A, vol. 1186, nos 1–2,‎ , p. 380–390 (PMID 18035363, DOI 10.1016/j.chroma.2007.11.002) modifier
  • C. Sauer, F. Peters, A. Schwaninger, M. Meyer et H. Maurer, « Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine », Biochemical pharmacology, vol. 77, no 3,‎ , p. 444–450 (PMID 19022226, DOI 10.1016/j.bcp.2008.10.024) modifier
  • M. A. Iorio, L. Tomassini, M. V. Mattson, C. George et A. E. Jacobson, « Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine », Journal of Medicinal Chemistry, vol. 34, no 8,‎ , p. 2615–2623 (PMID 1875352, DOI 10.1021/jm00112a041) modifier
  • A. Ahmadi et A. Mahmoudi, « Synthesis with improved yield and study on the analgesic effect of 2-methoxyphencyclidine », Arzneimittel-Forschung, vol. 56, no 5,‎ , p. 346–350 (PMID 16821645, DOI 10.1055/s-0031-1296732) modifier
  • J. Wallach, G. D. Paoli, A. Adejare et S. D. Brandt, « Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues », Drug Testing and Analysis, vol. 6, nos 7–8,‎ , p. 633–50 (PMID 23554350, DOI 10.1002/dta.1468) modifier
  • J. Vignon, V. Pinet, C. Cerruti, J. M. Kamenka et R. Chicheportiche, « 3HN-1-(2-benzo(b)thiophenyl)cyclohexylpiperidine (3HBTCP): A new phencyclidine analog selective for the dopamine uptake complex », European Journal of Pharmacology, vol. 148, no 3,‎ , p. 427–436 (PMID 3384005, DOI 10.1016/0014-2999(88)90122-7) modifier

wiley.com

onlinelibrary.wiley.com

  • H. Morris et J. Wallach, « From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs », Drug Testing and Analysis, vol. 6, nos 7-8,‎ , p. 614–32 (PMID 24678061, DOI 10.1002/dta.1620, lire en ligne)